Neuromuscular blockade reversal agent

This page covers all Neuromuscular blockade reversal agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Acetylcholinesterase or neuromuscular blocking agents (depending on specific agent).

Targets

Acetylcholinesterase or neuromuscular blocking agents (depending on specific agent)

Marketed (1)

• Reversal of superficial neuromuscular blockade · Pontificia Universidade Catolica de Sao Paulo · Anesthesiology
  This drug reverses neuromuscular blockade by antagonizing the effects of neuromuscular blocking agents at the neuromuscular junction.

Patent intelligence

• neuromuscular blockade reversal agent patent landscape — aggregated cliff calendar, attackable patents, originator estates